← All stocks

AZN vs MRK

AstraZeneca PLC Ordinary Shares vs Merck & Company Inc. Common Stock (new). Side-by-side ACCE scores, valuation, profitability, and growth.

AZN
AstraZeneca PLC Ordinary Shares
Healthcare
166.08
257.57B
MRK
Merck & Company Inc. Common Stock (new)
Healthcare
146.87
362.35B
ACCE scores
AZN
MRK
Composite score
Out of 100
59
54
Growth
40
28
Value
64
39
Quality
84
50
Momentum
47
97
Valuation
AZN
MRK
Price
166.08
146.87
Market cap
257.57B
362.35B
Trailing P/E
24.86
117.50
Forward P/E
14.45
15.15
EV / EBITDA
14.06
28.40
Dividend yield
1.9%
2.3%
Profitability
AZN
MRK
ROE
22.0%
7.0%
Net margin
17.0%
4.8%
Debt / equity
0.57
0.94
Free cash flow
8.67B
12.36B
Growth
AZN
MRK
Revenue growth (YoY)
6.4%
5.1%
Earnings growth (YoY)
2.5%
-19.3%
Analyst target
212.17
152.96
See full analysis